Literature DB >> 21861760

Continuous antagonism by Dkk1 counter activates canonical Wnt signaling and promotes cardiomyocyte differentiation of embryonic stem cells.

Meena Rai1, Joel M Walthall, Jianyong Hu, Antonis K Hatzopoulos.   

Abstract

Embryonic stem (ES) cells give rise to mesodermal progenitors that differentiate to hematopoietic and cardiovascular cells. The wnt signaling pathway plays multiple roles in cardiovascular development through a network of intracellular effectors. To monitor global changes in wnt signaling during ES cell differentiation, we generated independent ES cell lines carrying the luciferase gene under promoters that uniquely respond to specific wnt pathway branches. Our results show that successive, mutually exclusive waves of noncanonical and canonical wnt signaling precede mesoderm differentiation. Blocking the initial noncanonical JNK/AP-1 signaling with SP60125 aborts cardiovascular differentiation and promotes hematopoiesis, whereas interference with the subsequent peak of canonical wnt signaling using Dkk1 has the opposite effect. Dkk1 blockade triggers counter mechanisms that lead to delayed and extended activation of canonical wnt signaling and mesoderm differentiation that appear to favor the cardiomyocytic lineage at the expense of hematopoietic cells. The cardiomyocytic yield can be further enhanced by overexpression of Wnt11 leading to approximately 95-fold enrichment in contracting cells. Our results suggest that the initial noncanonical wnt signaling is necessary for subsequent activation of canonical signaling and that the latter operates under a regulatory loop which responds to suppression with hyperactivation of compensatory mechanisms. This model provides new insights on wnt signaling during ES cell differentiation and points to a method to induce cardiomyocytic differentiation without precise timing of wnt signaling manipulation. Taking into account the heterogeneity of pluripotent cells, these findings might present an advantage to enhance the cardiogenic potential of stem cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21861760      PMCID: PMC3245675          DOI: 10.1089/scd.2011.0326

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  56 in total

1.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

2.  Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.

Authors:  Sylvia Niebruegge; Céline L Bauwens; Raheem Peerani; Nimalan Thavandiran; Stephane Masse; Elias Sevaptisidis; Kumar Nanthakumar; Kim Woodhouse; Mansoor Husain; Eugenia Kumacheva; Peter W Zandstra
Journal:  Biotechnol Bioeng       Date:  2009-02-01       Impact factor: 4.530

3.  Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories.

Authors:  Céline Liu Bauwens; Raheem Peerani; Sylvia Niebruegge; Kimberly A Woodhouse; Eugenia Kumacheva; Mansoor Husain; Peter W Zandstra
Journal:  Stem Cells       Date:  2008-06-26       Impact factor: 6.277

Review 4.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

Review 5.  Cardiogenesis and the complex biology of regenerative cardiovascular medicine.

Authors:  Kenneth R Chien; Ibrahim J Domian; Kevin Kit Parker
Journal:  Science       Date:  2008-12-05       Impact factor: 47.728

6.  Functional cardiomyocytes derived from human induced pluripotent stem cells.

Authors:  Jianhua Zhang; Gisela F Wilson; Andrew G Soerens; Chad H Koonce; Junying Yu; Sean P Palecek; James A Thomson; Timothy J Kamp
Journal:  Circ Res       Date:  2009-02-12       Impact factor: 17.367

7.  Wnt/beta-catenin signaling acts at multiple developmental stages to promote mammalian cardiogenesis.

Authors:  Chulan Kwon; Kimberly R Cordes; Deepak Srivastava
Journal:  Cell Cycle       Date:  2008-12-13       Impact factor: 4.534

Review 8.  Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease.

Authors:  Konstantinos D Boudoulas; Antonis K Hatzopoulos
Journal:  Dis Model Mech       Date:  2009 Jul-Aug       Impact factor: 5.758

9.  Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction.

Authors:  Koichi Kobayashi; Min Luo; Yue Zhang; David C Wilkes; Gaoxiang Ge; Thomas Grieskamp; Chikaomi Yamada; Ting-Chun Liu; Guorui Huang; Craig T Basson; Andreas Kispert; Daniel S Greenspan; Thomas N Sato
Journal:  Nat Cell Biol       Date:  2008-12-14       Impact factor: 28.824

10.  Notch signaling respecifies the hemangioblast to a cardiac fate.

Authors:  Vincent C Chen; Robert Stull; Daniel Joo; Xin Cheng; Gordon Keller
Journal:  Nat Biotechnol       Date:  2008-09-28       Impact factor: 54.908

View more
  12 in total

Review 1.  The role of Wnt signaling in hematopoietic stem cell development.

Authors:  Jenna Richter; David Traver; Karl Willert
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-05-16       Impact factor: 8.250

2.  Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2.

Authors:  Jeffery B Bylund; Antonis K Hatzopoulos
Journal:  J Vis Exp       Date:  2016-03-10       Impact factor: 1.355

Review 3.  Wnt signaling in cardiovascular disease: opportunities and challenges.

Authors:  Austin Gay; Dwight A Towler
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

4.  Gremlin 2 promotes differentiation of embryonic stem cells to atrial fate by activation of the JNK signaling pathway.

Authors:  Vineeta Tanwar; Jeffery B Bylund; Jianyong Hu; Jingbo Yan; Joel M Walthall; Amrita Mukherjee; William H Heaton; Wen-Der Wang; Franck Potet; Meena Rai; Sabina Kupershmidt; Ela W Knapik; Antonis K Hatzopoulos
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

Review 5.  Potential for pharmacological manipulation of human embryonic stem cells.

Authors:  Stuart P Atkinson; Majlinda Lako; Lyle Armstrong
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

6.  Rho-associated protein kinases play an important role in the differentiation of rat adipose-derived stromal cells into cardiomyocytes in vitro.

Authors:  Lili Zhao; Gongshe Yang; Xin Zhao
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

7.  The Wnt inhibitor Dkk1 is required for maintaining the normal cardiac differentiation program in Xenopus laevis.

Authors:  Yanchun Guo; Tatjana Dorn; Susanne J Kühl; Alexander Linnemann; Melanie Rothe; Astrid S Pfister; Seppo Vainio; Karl-Ludwig Laugwitz; Alessandra Moretti; Michael Kühl
Journal:  Dev Biol       Date:  2019-02-21       Impact factor: 3.582

8.  Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm.

Authors:  Iris I Müller; David B Melville; Vineeta Tanwar; Witold M Rybski; Amrita Mukherjee; M Benjamin Shoemaker; Wan-Der Wang; John A Schoenhard; Dan M Roden; Dawood Darbar; Ela W Knapik; Antonis K Hatzopoulos
Journal:  Dis Model Mech       Date:  2012-12-07       Impact factor: 5.758

9.  Effect of oxygen on cardiac differentiation in mouse iPS cells: role of hypoxia inducible factor-1 and Wnt/beta-catenin signaling.

Authors:  Tanya L Medley; Milena Furtado; Nicholas T Lam; Rejhan Idrizi; David Williams; Paul J Verma; Mauro Costa; David M Kaye
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

10.  Polycyclic Aromatic Hydrocarbons from Particulate Matter 2.5 (PM2.5) in Polluted Air Changes miRNA Profile Related to Cardiovascular Disease.

Authors:  Xiaonan He; Yu Chen; Cheng Zhang; Wei Gong; Xinyong Zhang; Shaoping Nie
Journal:  Med Sci Monit       Date:  2018-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.